Results 11 to 20 of about 11,904 (210)

Rivastigmine to treat anticholinergic toxicity following drug overdose – case series

Toxicology Communications
Introduction Overdose involving anticholinergic agents frequently cause delirium and agitation, for which the antidote of choice is physostigmine. Due to unpredictable physostigmine availability, rivastigmine has been proposed as an alternative therapy ...
Joseph E. Lambson, Paul Hinckley, Michael J. Moss   +2 more
doaj   +2 more sources

Rivastigmine in Chinese patients with subcortical vascular dementia

Neuropsychiatric Disease and Treatment, 2007
Vincent Mok1, Adrian Wong1, Simon Ho2, Thomas Leung1, Wynnie WM Lam2, Ka Sing Wong11Department of Medicine and Therapeutics; 2Department of Radiology and Organ Imaging, The Chinese University of Hong Kong, Shatin, Hong Kong, ChinaBackground: We explored ...
Vincent Mok, Adrian Wong, Simon Ho, Thomas Leung, Wynnie WM Lam, et al   +5 more
doaj   +1 more source

The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats

Neuropsychiatric Disease and Treatment, 2008
Haris Carageorgiou1, Antonios C Sideris1, Ioanna Messari1, Chrissoula I Liakou1, Stylianos Tsakiris21Department of Pharmacology, 2Department of Physiology, Medical School, University of Athens, Athens, GreeceAbstract: We investigated the effects of ...
Haris Carageorgiou, Antonios C Sideris, Ioanna Messari, Chrissoula I Liakou, Stylianos Tsakiris   +4 more
doaj   +1 more source

Rivastigmine for the treatment of dementia associated with Parkinson’s disease

Neuropsychiatric Disease and Treatment, 2007
Jennifer L Reingold, John C Morgan, Kapil D SethiMovement Disorders Program, Department of Neurology, Medical College of Georgia, Augusta, GA, USAAbstract: Parkinson’s disease (PD) afflicts millions of people worldwide and leads to cognitive ...
Jennifer L Reingold, John C Morgan, Kapil D Sethi   +2 more
doaj   +1 more source

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Clinical Interventions in Aging, 2017
Nagaendran Kandiah,1,2 Ming-Chyi Pai,3,4 Vorapun Senanarong,5 Irene Looi,6,7 Encarnita Ampil,8 Kyung Won Park,9 Ananda Krishna Karanam,10 Stephen Christopher11 1Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital, 2Duke-NUS,
Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S   +7 more
doaj   +1 more source

Adverse drug events affecting medication persistence with rivastigmine patch application

Patient Preference and Adherence, 2018
Takashi Osada,1 Norio Watanabe,1 Naomitsu Asano,2 Yuzo Adachi,2 Keiko Yamamura1 1Clinical Pharmacy, School of Pharmacy, Aichi Gakuin University, Nagoya, Aichi, Japan; 2Sasayuri Pharmacy, Toki, Gifu, Japan Purpose: The rivastigmine transdermal patch ...
Osada T, Watanabe N, Asano N, Adachi Y, Yamamura K   +4 more
doaj   +1 more source

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer’s disease in daily practice

Neuropsychiatric Disease and Treatment, 2012
Johannes Seibert1, Ferenc Tracik2,3, Konstantin Articus2, Stefan Spittler41Outpatient Clinic, Heidelberg, Germany; 2Novartis Pharma, Nürnberg, Germany; 3Department of Neurology, Heinrich-Heine University, Düsseldorf, Germany; 4Alexianer
Seibert J, Tracik F, Articus K, Spittler S   +3 more
doaj   +1 more source

Potential of <i>Aeginetia indica</i> for Alzheimer's Disease Management: In Vitro, In Vivo, and Computational Insights. [PDF]

Food Sci Nutr
MeOH extract of Aeginetia indica (AİME); chromatographic study: LCMS/MS and GCMS; in vitro assays: AChE assays → ↓ AChE level, ↓ inflammation level and antioxidant assays → ROS; in vivo anti‐inflammatory study: ↓ inflammation level; molecular docking → molecular dynamics simulations: acacetin and acteoside.
Bhuiyan MR, Reza MS, Shuvo SR, Yilmaz MA, Siam SMM, Sakib MS, Cakir O, Durjoy MNI, Tarhan A, Eruygur N, Shahid Ud Daula AFM.   +10 more
europepmc   +2 more sources

Deciphering Antidiabetic, Anti-Inflammatory, and Anti-Cholinergic Bioactivities of Withania somnifera (L) Dunal Root Extract: An In Vitro and In Silico Investigation. [PDF]

Chem Biodivers
In this investigation, Withania somnifera root ethanol extract displays anti‐inflammatory and antidiabetic properties. Though compounds including withasomniferolide B and sitoindoside IX have been previously identified as phytoconstituents in the plant, in silico analysis from this study revealed them as new lead compounds that could act as potential ...
Mulelu L, Manjia JN, Olofinsan KA, Xulu L, Matsabisa MG.   +4 more
europepmc   +2 more sources

Clinicial and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review [PDF]

, 2001
Background Alzheimer’s disease is the most common cause of dementia and is characterised by an insidious onset and slow deterioration. The estimated prevalence of Alzheimer’s disease for a standard health authority (500,000 people) is about 3330. Current
A. Clegg, N. Waugh, S. De Broe, Gerard, K., Bryant, J., K. Gerard, Clegg, A. J., McIntyre, Linda, L. McIntyre, Bryant, Jackie, Gerard, Karen, Waugh, Norman, McIntyre, L., Nicholson, T., T. Nicholson, De Broe, S., Clegg, A., Waugh, N., J. Bryant   +18 more
core   +1 more source